|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
Zürcherstrasse 19, Rapperswil, Sankt Gallen 8640, CH
|
|
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology.
Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.
|
Neovii Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Neovii email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Neovii customer service number in your country click here to find.
Belen Maria Podesta is the CEO of Neovii. To contact Belen Maria Podesta email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.